APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glutamate Receptor Ionotropic NMDA 2B

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Glutamate Receptor Ionotropic NMDA 2B Industry Growth and Trends Forecast to 2032

26 December 202595 pages

Choose your research edition.

Industry ResearchGlutamate Receptor Ionotropic NMDA 2B Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Glutamate Receptor Ionotropic NMDA 2B Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Glutamate Receptor Ionotropic NMDA 2B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glutamate Receptor Ionotropic NMDA 2B Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Glutamate Receptor Ionotropic NMDA 2B Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Glutamate Receptor Ionotropic NMDA 2B market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Glutamate Receptor Ionotropic NMDA 2B is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Glutamate Receptor Ionotropic NMDA 2B is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glutamate Receptor Ionotropic NMDA 2B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glutamate Receptor Ionotropic NMDA 2B include Johnson & Johnson, Novartis AG, UCB S.A., NeurOp, Inc, Luc Therapeutics, Inc., Cerecor Inc., Bristol-Myers Squibb Company and BioCrea GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Glutamate Receptor Ionotropic NMDA 2B market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Glutamate Receptor Ionotropic NMDA 2B market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glutamate Receptor Ionotropic NMDA 2B market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glutamate Receptor Ionotropic NMDA 2B.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Glutamate Receptor Ionotropic NMDA 2B market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Glutamate Receptor Ionotropic NMDA 2B Market by Company

Johnson & Johnson

Novartis AG

UCB S.A.

NeurOp, Inc

Luc Therapeutics, Inc.

Cerecor Inc.

Bristol-Myers Squibb Company

BioCrea GmbH

Glutamate Receptor Ionotropic NMDA 2B Segment by Type

JNJ-0808

Radiprodil

NP-11948

NP-10679

Neu-2000

Others

Glutamate Receptor Ionotropic NMDA 2B Segment by Application

Burns

Acute Ischemic Stroke

Brain Ischemia

Autism

Others

Glutamate Receptor Ionotropic NMDA 2B Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glutamate Receptor Ionotropic NMDA 2B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glutamate Receptor Ionotropic NMDA 2B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glutamate Receptor Ionotropic NMDA 2B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glutamate Receptor Ionotropic NMDA 2B manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Glutamate Receptor Ionotropic NMDA 2B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of JNJ-0808 Table 2. Major Company of Radiprodil Table 3. Major Company of NP-11948 Table 4. Major Company of NP-10679 Table 5. Major Company of Neu-2000 Table 6. Major Company of Others Table 7. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (W Units) Table 9. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type (2021-2026) Table 10. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (US$ Million) Table 11. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type (2021-2026) Table 12. Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2021-2026) & (US$/Unit) Table 13. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2027-2032) & (W Units) Table 14. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type (2027-2032) Table 15. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2027-2032) & (US$ Million) Table 16. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type (2027-2032) Table 17. Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2027-2032) & (US$/Unit) Table 18. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (W Units) Table 19. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (W Units) Table 21. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (W Units) Table 23. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (W Units) Table 25. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (W Units) Table 27. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (US$ Million) Table 28. Glutamate Receptor Ionotropic NMDA 2B Industry Trends Table 29. Glutamate Receptor Ionotropic NMDA 2B Industry Drivers Table 30. Glutamate Receptor Ionotropic NMDA 2B Industry Opportunities and Challenges Table 31. Glutamate Receptor Ionotropic NMDA 2B Industry Restraints Table 32. Global Glutamate Receptor Ionotropic NMDA 2B Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Company (2021-2026) Table 34. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Company (2021-2026) & (W Units) Table 35. Global Glutamate Receptor Ionotropic NMDA 2B Sales Share by Company (2021-2026) Table 36. Global Glutamate Receptor Ionotropic NMDA 2B Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Glutamate Receptor Ionotropic NMDA 2B Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Glutamate Receptor Ionotropic NMDA 2B Major Company Production Sites and Headquarters Table 39. Global Glutamate Receptor Ionotropic NMDA 2B Company, Product Type & Application Table 40. Global Glutamate Receptor Ionotropic NMDA 2B Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Glutamate Receptor Ionotropic NMDA 2B by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Glutamate Receptor Ionotropic NMDA 2B Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2021-2026) & (W Units) Table 45. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Region (2021-2026) Table 46. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2021-2026) & (US$ Million) Table 47. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Region (2021-2026) Table 48. Global Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2027-2032) & (W Units) Table 50. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Region (2027-2032) Table 51. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2027-2032) & (US$ Million) Table 52. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Region (2027-2032) Table 53. Global Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (W Units) Table 56. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application (2021-2026) Table 57. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (US$ Million) Table 58. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application (2021-2026) Table 59. Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2021-2026) & (US$/Unit) Table 60. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2027-2032) & (W Units) Table 61. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application (2027-2032) Table 62. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2027-2032) & (US$ Million) Table 63. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application (2027-2032) Table 64. Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2027-2032) & (US$/Unit) Table 65. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (W Units) Table 66. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (W Units) Table 68. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (W Units) Table 70. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (W Units) Table 72. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (W Units) Table 74. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (US$ Million) Table 75. Johnson & Johnson Company Information Table 76. Johnson & Johnson Business Overview Table 77. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 79. Johnson & Johnson Recent Development Table 80. Novartis AG Company Information Table 81. Novartis AG Business Overview Table 82. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 84. Novartis AG Recent Development Table 85. UCB S.A. Company Information Table 86. UCB S.A. Business Overview Table 87. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 89. UCB S.A. Recent Development Table 90. NeurOp, Inc Company Information Table 91. NeurOp, Inc Business Overview Table 92. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 94. NeurOp, Inc Recent Development Table 95. Luc Therapeutics, Inc. Company Information Table 96. Luc Therapeutics, Inc. Business Overview Table 97. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 99. Luc Therapeutics, Inc. Recent Development Table 100. Cerecor Inc. Company Information Table 101. Cerecor Inc. Business Overview Table 102. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 104. Cerecor Inc. Recent Development Table 105. Bristol-Myers Squibb Company Company Information Table 106. Bristol-Myers Squibb Company Business Overview Table 107. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 109. Bristol-Myers Squibb Company Recent Development Table 110. BioCrea GmbH Company Information Table 111. BioCrea GmbH Business Overview Table 112. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 114. BioCrea GmbH Recent Development Table 115. North America Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 116. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026) & (W Units) Table 117. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2021-2026) Table 118. North America Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2027-2032) & (W Units) Table 119. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share Forecast by Country (2027-2032) Table 120. North America Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 121. North America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country (2021-2026) & (US$ Million) Table 122. North America Glutamate Receptor Ionotropic NMDA 2B Market Share by Country (2021-2026) Table 123. North America Glutamate Receptor Ionotropic NMDA 2B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 124. North America Glutamate Receptor Ionotropic NMDA 2B Market Share Forecast by Country (2027-2032) Table 125. Europe Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 126. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026) & (W Units) Table 127. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2021-2026) Table 128. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2027-2032) & (W Units) Table 129. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share Forecast by Country (2027-2032) Table 130. Europe Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. Europe Glutamate Receptor Ionotropic NMDA 2B Market Size by Country (2021-2026) & (US$ Million) Table 132. Europe Glutamate Receptor Ionotropic NMDA 2B Market Share by Country (2021-2026) Table 133. Europe Glutamate Receptor Ionotropic NMDA 2B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. Europe Glutamate Receptor Ionotropic NMDA 2B Market Share Forecast by Country (2027-2032) Table 135. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 136. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026) & (W Units) Table 137. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2021-2026) Table 138. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2027-2032) & (W Units) Table 139. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share Forecast by Country (2027-2032) Table 140. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size by Country (2021-2026) & (US$ Million) Table 142. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Share by Country (2021-2026) Table 143. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Share Forecast by Country (2027-2032) Table 145. Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 146. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026) & (W Units) Table 147. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2021-2026) Table 148. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2027-2032) & (W Units) Table 149. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share Forecast by Country (2027-2032) Table 150. Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country (2021-2026) & (US$ Million) Table 152. Latin America Glutamate Receptor Ionotropic NMDA 2B Market Share by Country (2021-2026) Table 153. Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Latin America Glutamate Receptor Ionotropic NMDA 2B Market Share Forecast by Country (2027-2032) Table 155. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 156. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026) & (W Units) Table 157. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2021-2026) Table 158. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2027-2032) & (W Units) Table 159. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share Forecast by Country (2027-2032) Table 160. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size by Country (2021-2026) & (US$ Million) Table 162. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Share by Country (2021-2026) Table 163. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Share Forecast by Country (2027-2032) Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Glutamate Receptor Ionotropic NMDA 2B Distributors List Table 168. Glutamate Receptor Ionotropic NMDA 2B Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Glutamate Receptor Ionotropic NMDA 2B Image Figure 2. Global Glutamate Receptor Ionotropic NMDA 2B Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glutamate Receptor Ionotropic NMDA 2B Market Size (2021-2032) & (US$ Million) Figure 4. Global Glutamate Receptor Ionotropic NMDA 2B Sales (2021-2032) & (W Units) Figure 5. JNJ-0808 Image Figure 6. Global JNJ-0808 Sales YoY Growth (2021-2032) & (W Units) Figure 7. Radiprodil Image Figure 8. Global Radiprodil Sales YoY Growth (2021-2032) & (W Units) Figure 9. NP-11948 Image Figure 10. Global NP-11948 Sales YoY Growth (2021-2032) & (W Units) Figure 11. NP-10679 Image Figure 12. Global NP-10679 Sales YoY Growth (2021-2032) & (W Units) Figure 13. Neu-2000 Image Figure 14. Global Neu-2000 Sales YoY Growth (2021-2032) & (W Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 17. Global Glutamate Receptor Ionotropic NMDA 2B Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Type 2025 VS 2032 Figure 19. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type in 2025 Figure 20. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type in 2025 Figure 21. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type in 2025 Figure 22. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type in 2025 Figure 25. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Glutamate Receptor Ionotropic NMDA 2B Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Burns Image Figure 32. Global Burns Sales YoY Growth (2021-2032) & (W Units) Figure 33. Acute Ischemic Stroke Image Figure 34. Global Acute Ischemic Stroke Sales YoY Growth (2021-2032) & (W Units) Figure 35. Brain Ischemia Image Figure 36. Global Brain Ischemia Sales YoY Growth (2021-2032) & (W Units) Figure 37. Autism Image Figure 38. Global Autism Sales YoY Growth (2021-2032) & (W Units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 41. Global Glutamate Receptor Ionotropic NMDA 2B Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Application 2025 VS 2032 Figure 43. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application in 2025 Figure 44. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application in 2025 Figure 45. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application in 2025 Figure 46. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application in 2025 Figure 49. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application in 2025 Figure 53. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. North America Glutamate Receptor Ionotropic NMDA 2B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Glutamate Receptor Ionotropic NMDA 2B Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Glutamate Receptor Ionotropic NMDA 2B Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 66. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Glutamate Receptor Ionotropic NMDA 2B Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 70. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Glutamate Receptor Ionotropic NMDA 2B Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Glutamate Receptor Ionotropic NMDA 2B Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • JNJ-0808
  • Radiprodil
  • NP-11948
  • NP-10679
  • Neu-2000
  • Others
Applications
  • Burns
  • Acute Ischemic Stroke
  • Brain Ischemia
  • Autism
  • Others
Companies covered
  • Johnson & Johnson
  • Novartis AG
  • UCB S.A.
  • NeurOp, Inc
  • Luc Therapeutics, Inc.
  • Cerecor Inc.
  • Bristol-Myers Squibb Company
  • BioCrea GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Glutamate Receptor Ionotropic NMDA 2B Market by Type
  6. 1.3.1 JNJ-0808
  7. 1.3.2 Radiprodil
  8. 1.3.3 NP-11948
  9. 1.3.4 NP-10679
  10. 1.3.5 Neu-2000
  11. 1.3.6 Others
  12. 1.4 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Type
  13. 1.4.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Glutamate Receptor Ionotropic NMDA 2B Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Glutamate Receptor Ionotropic NMDA 2B Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Glutamate Receptor Ionotropic NMDA 2B Industry Trends
  2. 2.2 Glutamate Receptor Ionotropic NMDA 2B Industry Drivers
  3. 2.3 Glutamate Receptor Ionotropic NMDA 2B Industry Opportunities and Challenges
  4. 2.4 Glutamate Receptor Ionotropic NMDA 2B Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2026)
  2. 3.2 Global Top Players by Glutamate Receptor Ionotropic NMDA 2B Sales (2021-2026)
  3. 3.3 Global Top Players by Glutamate Receptor Ionotropic NMDA 2B Price (2021-2026)
  4. 3.4 Global Glutamate Receptor Ionotropic NMDA 2B Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glutamate Receptor Ionotropic NMDA 2B Major Company Production Sites & Headquarters
  6. 3.6 Global Glutamate Receptor Ionotropic NMDA 2B Company, Product Type & Application
  7. 3.7 Global Glutamate Receptor Ionotropic NMDA 2B Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glutamate Receptor Ionotropic NMDA 2B Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glutamate Receptor Ionotropic NMDA 2B Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glutamate Receptor Ionotropic NMDA 2B Tier 1, Tier 2, and Tier 3
4 Glutamate Receptor Ionotropic NMDA 2B Regional Status and Outlook
  1. 4.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Glutamate Receptor Ionotropic NMDA 2B Historic Market Size by Region
  3. 4.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Glutamate Receptor Ionotropic NMDA 2B Forecasted Market Size by Region
  7. 4.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glutamate Receptor Ionotropic NMDA 2B by Application
  1. 5.1 Glutamate Receptor Ionotropic NMDA 2B Market by Application
  2. 5.1.1 Burns
  3. 5.1.2 Acute Ischemic Stroke
  4. 5.1.3 Brain Ischemia
  5. 5.1.4 Autism
  6. 5.1.5 Others
  7. 5.2 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Application
  8. 5.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 UCB S.A.
  14. 6.3.1 UCB S.A. Company Information
  15. 6.3.2 UCB S.A. Business Overview
  16. 6.3.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  18. 6.3.5 UCB S.A. Recent Developments
  19. 6.4 NeurOp, Inc
  20. 6.4.1 NeurOp, Inc Company Information
  21. 6.4.2 NeurOp, Inc Business Overview
  22. 6.4.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  24. 6.4.5 NeurOp, Inc Recent Developments
  25. 6.5 Luc Therapeutics, Inc.
  26. 6.5.1 Luc Therapeutics, Inc. Company Information
  27. 6.5.2 Luc Therapeutics, Inc. Business Overview
  28. 6.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  30. 6.5.5 Luc Therapeutics, Inc. Recent Developments
  31. 6.6 Cerecor Inc.
  32. 6.6.1 Cerecor Inc. Company Information
  33. 6.6.2 Cerecor Inc. Business Overview
  34. 6.6.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  36. 6.6.5 Cerecor Inc. Recent Developments
  37. 6.7 Bristol-Myers Squibb Company
  38. 6.7.1 Bristol-Myers Squibb Company Company Information
  39. 6.7.2 Bristol-Myers Squibb Company Business Overview
  40. 6.7.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  42. 6.7.5 Bristol-Myers Squibb Company Recent Developments
  43. 6.8 BioCrea GmbH
  44. 6.8.1 BioCrea GmbH Company Information
  45. 6.8.2 BioCrea GmbH Business Overview
  46. 6.8.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  48. 6.8.5 BioCrea GmbH Recent Developments
7 North America by Country
  1. 7.1 North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country
  2. 7.1.1 North America Glutamate Receptor Ionotropic NMDA 2B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026)
  4. 7.1.3 North America Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2027-2032)
  5. 7.2 North America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
  6. 7.2.1 North America Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country (2021-2026)
  8. 7.2.3 North America Glutamate Receptor Ionotropic NMDA 2B Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country
  2. 8.1.1 Europe Glutamate Receptor Ionotropic NMDA 2B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026)
  4. 8.1.3 Europe Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
  6. 8.2.1 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size by Country (2021-2026)
  8. 8.2.3 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Country
  2. 9.1.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
  6. 9.2.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Glutamate Receptor Ionotropic NMDA 2B Sales by Country
  2. 10.1.1 South America Glutamate Receptor Ionotropic NMDA 2B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026)
  4. 10.1.3 South America Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2027-2032)
  5. 10.2 South America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
  6. 10.2.1 South America Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country (2021-2026)
  8. 10.2.3 South America Glutamate Receptor Ionotropic NMDA 2B Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country
  2. 11.1.1 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
  6. 11.2.1 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Glutamate Receptor Ionotropic NMDA 2B Value Chain Analysis
  2. 12.1.1 Glutamate Receptor Ionotropic NMDA 2B Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Glutamate Receptor Ionotropic NMDA 2B Production Mode & Process
  7. 12.2 Glutamate Receptor Ionotropic NMDA 2B Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
  10. 12.2.3 Glutamate Receptor Ionotropic NMDA 2B Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst